Anthem (NYSE:ANTM) was upgraded by research analysts at Jefferies Group from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, January 12th, Marketbeat.com reports. The firm currently has a $211.00 price objective on the stock, down from their previous price objective of $235.00. Jefferies Group’s price target indicates a potential downside of 10.93% from the stock’s current price. Jefferies Group also issued estimates for Anthem’s Q3 2018 earnings at $3.25 EPS and Q4 2018 earnings at $1.85 EPS.
Several other equities analysts also recently commented on the stock. Royal Bank of Canada reissued a “buy” rating on shares of Anthem in a research report on Thursday, January 4th. Zacks Investment Research upgraded shares of Anthem from a “hold” rating to a “buy” rating and set a $253.00 target price for the company in a research note on Wednesday, January 3rd. Goldman Sachs Group assumed coverage on shares of Anthem in a research note on Wednesday, January 3rd. They issued a “neutral” rating and a $243.00 target price for the company. Piper Jaffray Companies upgraded shares of Anthem from a “neutral” rating to an “overweight” rating and set a $151.00 target price for the company in a research note on Wednesday, January 3rd. Finally, ValuEngine upgraded shares of Anthem from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $230.80.
Shares of Anthem (NYSE ANTM) traded down $2.30 during trading hours on Friday, hitting $236.88. The company had a trading volume of 447,375 shares, compared to its average volume of 1,617,580. The company has a current ratio of 1.55, a quick ratio of 1.51 and a debt-to-equity ratio of 0.66. Anthem has a twelve month low of $155.35 and a twelve month high of $267.95. The stock has a market capitalization of $60,920.00, a price-to-earnings ratio of 16.46, a price-to-earnings-growth ratio of 1.38 and a beta of 0.83.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, January 31st. The company reported $1.29 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.25 by $0.04. The business had revenue of $22.45 billion during the quarter, compared to analyst estimates of $22.17 billion. Anthem had a return on equity of 12.29% and a net margin of 4.27%. Anthem’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the company earned $1.76 earnings per share. sell-side analysts anticipate that Anthem will post 15.1 earnings per share for the current fiscal year.
Anthem declared that its Board of Directors has approved a share repurchase program on Thursday, December 7th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to buy shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.
In other news, SVP Ronald W. Penczek sold 978 shares of Anthem stock in a transaction that occurred on Tuesday, November 7th. The shares were sold at an average price of $217.42, for a total value of $212,636.76. Following the completion of the transaction, the senior vice president now owns 1,222 shares in the company, valued at $265,687.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Joseph Swedish sold 67,500 shares of Anthem stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $235.87, for a total transaction of $15,921,225.00. Following the completion of the transaction, the insider now owns 134,043 shares of the company’s stock, valued at approximately $31,616,722.41. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 105,634 shares of company stock valued at $24,682,425. Corporate insiders own 0.36% of the company’s stock.
Large investors have recently bought and sold shares of the company. Xact Kapitalforvaltning AB increased its holdings in shares of Anthem by 1.9% in the third quarter. Xact Kapitalforvaltning AB now owns 46,610 shares of the company’s stock valued at $8,850,000 after purchasing an additional 873 shares in the last quarter. British Airways Pensions Investment Management Ltd grew its holdings in Anthem by 9.4% during the 3rd quarter. British Airways Pensions Investment Management Ltd now owns 191,646 shares of the company’s stock worth $36,380,000 after acquiring an additional 16,403 shares during the period. Farmers & Merchants Trust Co of Chambersburg PA grew its holdings in Anthem by 10.0% during the 3rd quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 8,214 shares of the company’s stock worth $1,560,000 after acquiring an additional 750 shares during the period. Ladenburg Thalmann Financial Services Inc. grew its holdings in Anthem by 15.6% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 8,219 shares of the company’s stock worth $1,561,000 after acquiring an additional 1,109 shares during the period. Finally, Laurel Wealth Advisors Inc. acquired a new stake in Anthem during the 3rd quarter worth $295,000. Institutional investors own 87.41% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/05/anthem-antm-upgraded-to-buy-by-jefferies-group.html.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.